MicroRNAs of the immune system: roles in inflammation and cancer

Jan Davidson-Moncada1, F Nina Papavasiliou, Wayne Tam

  • 1Laboratory of Lymphocyte Biology, The Rockefeller University, New York, New York 10065, USA.

Insights

MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression. This review focuses on their critical roles in immune system development, inflammation, and immune system cancers, highlighting miRNA dysregulation in oncogenesis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Immunology

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression post-transcriptionally.
  • These regulatory pathways are conserved across eukaryotes, impacting development.
  • miRNAs play crucial roles in immune system development and function.

Purpose of the Study:

  • To review the regulatory roles of miRNAs in gene expression.
  • To discuss the involvement of miRNAs in immune system development and function.
  • To explore the connection between miRNA dysregulation, inflammation, and oncogenesis.

Main Methods:

  • Literature review of miRNA function in gene regulation.
  • Analysis of miRNA involvement in hematopoiesis and immune responses.
  • Examination of miRNA dysregulation in immune system cancers.

Main Results:

  • miRNAs are key regulators of gene expression, affecting mRNA decay and translation.
  • miRNAs are essential for all aspects of immune system development and response.
  • miRNA dysregulation is implicated in the development and pathophysiology of immune system cancers.

Conclusions:

  • MicroRNAs are fundamental regulators of gene expression with broad biological significance.
  • Understanding miRNA function is crucial for comprehending immune system development, inflammation, and cancer.
  • Targeting miRNA pathways holds potential for therapeutic strategies in oncogenesis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...